ArticleThe Pan African medical journal2025
[HIV-pulmonary tuberculosis co-infection at the university clinics of Lubumbashi: epidemiological and clinical aspects].
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: this study aims to provide an overview of the epidemiological and clinical characteristics of HIV-pulmonary tuberculosis (TB) co-infection among patients treated at the University Clinics of Lubumbashi. Methods: we conducted a descriptive cross-sectional study based on the analysis of medical records of patients with tuberculosis admitted to the Internal Medicine Department of the University Clinics of Lubumbashi, located in the southeastern region of the Democratic Republic of the Congo, during the year 2019. Results: HIV-tuberculosis co-infection was identified in 37 out of 66 medical records reviewed (56.0%). Compared to HIV-negative patients, TB in HIV-positive individuals was more frequently observed in patients aged 40 years and older (56.8% vs. 34.4%, p = 0.004), in females (78.9% vs. 46.8%, p = 0.01), in cases of recurrent TB (37.8% vs. 27.5%), and in those with a history of diabetes mellitus (8.1% vs. 3.4%). Just over one-third of co-infected patients (37.4%) originated from the peripheral neighborhoods of the city of Lubumbashi, most of which are characterized by unfavorable socioeconomic conditions. Smear-negative forms of tuberculosis, lacking bacteriological confirmation, were predominant among co-infected patients (48.6% vs. 34.4%). Mortality rate at discharge was 13.5% among the co-infected patients. Mortality was associated with the following factors: smear-positive TB (21.0% vs. 5.5%), male sex (18.1% vs. 6.6%), diabetes mellitus (33.3% vs. 11.7%), and age over 40 years (19.0% vs. 6.2%). Conclusion: HIV-pulmonary tuberculosis co-infection is a frequent condition among inpatients at the University Clinics of Lubumbashi. The epidemiological and clinical profile is marked by the presence of factors that may adversely affect short-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.